Login Register Cart 0
Systematic Review Article

糖皮质激素给药在心脏骤停患者中的疗效：临床研究的系统综述

卷 29, 期 1, 2022

发表于: 31 May, 2021

页: [136 - 151] 页: 16

弟呕挨: 10.2174/0929867328666210531145617

价格: $65

摘要

背景：心脏骤停 （CA） 的病理生理学包括全身炎症反应过度激活、相对肾上腺皮质功能不全和糖萼损伤。皮质类固醇在防止内皮糖萼的干扰方面具有有益作用。目的：本系统评价的目的是确定糖皮质激素对心脏骤停患者的疗效。 方法：在2019年9月之前，我们检索了PubMed、Scopus、ISI Web of Science、Google Scholar和Cochrane中央注册库，以进行相关的临床试验和队列研究。 结果：我们检索了7项同行评审的已发表研究，用于系统评价。两项研究是评估147名患者的临床试验，而五项研究则说明了队列设计，评估了196，192名患者。总共评估了196，339名患者。有限的证据和相互矛盾的结果证实了糖皮质激素与心脏骤停患者生存之间的相关性。然而，在观察性研究中，这些药物与入院生存率、出院生存率和1年生存率之间的联系是强烈且一致的。 结论：关于糖皮质激素在CA中的疗效和安全性的临床证据仅限于方法不一致的观察性研究，以及样本量小的临床试验很少。然而，在心肺复苏 （CPR） 期间和之后补充糖皮质激素似乎在入院生存、出院生存、1 年生存率和提高自发循环 （ROSC） 率方面可能具有有益效果，特别是在血流动力学不稳定和心血管疾病（即难治性血流动力学休克）患者中。未来需要进行高质量、大规模、长期干预和精确基线特征的研究，以评估糖皮质激素在 CA 中的确切有效剂量、持续时间和疗效。

关键词: 心脏骤停，糖皮质激素，糖隼脱落，复苏后综合征，自发循环恢复，生存。

« Previous Next »
[1]
Jacobs, I.; Nadkarni, V.; Arrest, ITFoC. Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries: A statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian Resuscitation Council, New Zealand Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Councils of Southern Africa). Circulation, 2004, 110(21), 3385-3397.
[2]
Meaney, P.A.; Nadkarni, V.M.; Kern, K.B.; Indik, J.H.; Halperin, H.R.; Berg, R.A. Rhythms and outcomes of adult in-hospital cardiac arrest. Crit. Care Med., 2010, 38(1), 101-108.
[http://dx.doi.org/10.1097/CCM.0b013e3181b43282] [PMID: 19770741]
[3]
Mongardon, N.; Dumas, F.; Ricome, S.; Grimaldi, D.; Hissem, T.; Pène, F.; Cariou, A. Postcardiac arrest syndrome: From immediate resuscitation to long-term outcome. Ann. Intensive Care, 2011, 1(1), 45.
[http://dx.doi.org/10.1186/2110-5820-1-45] [PMID: 22053891]
[4]
Adrie, C.; Laurent, I.; Monchi, M.; Cariou, A.; Dhainaou, J.F.; Spaulding, C. Postresuscitation disease after cardiac arrest: A sepsis-like syndrome? Curr. Opin. Crit. Care, 2004, 10(3), 208-212.
[http://dx.doi.org/10.1097/01.ccx.0000126090.06275.fe] [PMID: 15166838]
[5]
Kolářová, H; Ambrůzová, B; Švihálková Šindlerová, L Modulation of endothelial glycocalyx structure under inflammatory conditions. Mediators Inflamm., 2014.694312.
[6]
Reitsma, S.; Slaaf, D.W.; Vink, H.; van Zandvoort, M.A.; oude Egbrink, M.G. The endothelial glycocalyx: Composition, functions, and visualization. Pflugers Arch., 2007, 454(3), 345-359.
[http://dx.doi.org/10.1007/s00424-007-0212-8] [PMID: 17256154]
[7]
Grundmann, S.; Fink, K.; Rabadzhieva, L.; Bourgeois, N.; Schwab, T.; Moser, M.; Bode, C.; Busch, H.J. Perturbation of the endothelial glycocalyx in post cardiac arrest syndrome. Resuscitation, 2012, 83(6), 715-720.
[http://dx.doi.org/10.1016/j.resuscitation.2012.01.028] [PMID: 22306259]
[8]
Jacob, M.; Saller, T.; Chappell, D.; Rehm, M.; Welsch, U.; Becker, B.F. Physiological levels of A-, B- and C-type natriuretic peptide shed the endothelial glycocalyx and enhance vascular permeability. Basic Res. Cardiol., 2013, 108(3), 347.
[http://dx.doi.org/10.1007/s00395-013-0347-z] [PMID: 23563917]
[9]
Nagao, K.; Hayashi, N.; Kanmatsuse, K.; Kikuchi, S.; Kikushima, K.; Watanabe, K.; Mukouyama, T. B-type natriuretic peptide as a marker of resuscitation in patients with cardiac arrest outside the hospital. Circ. J., 2004, 68(5), 477-482.
[http://dx.doi.org/10.1253/circj.68.477] [PMID: 15118292]
[10]
Wei, S.; Loyo-Berríos, N.I.; Haigney, M.C.; Cheng, H.; Pinnow, E.E.; Mitchell, K.R.; Beachy, J.H.; Woodward, A.M.; Wang, Y.; Curtis, J.P.; Marinac-Dabic, D. Elevated B-type natriuretic peptide is associated with increased in-hospital mortality or cardiac arrest in patients undergoing implantable cardioverter-defibrillator implantation. Circ. Cardiovasc. Qual. Outcomes, 2011, 4(3), 346-354.
[http://dx.doi.org/10.1161/CIRCOUTCOMES.110.943621] [PMID: 21487093]
[11]
Sodeck, G.H.; Domanovits, H.; Sterz, F.; Schillinger, M.; Losert, H.; Havel, C.; Kliegel, A.; Vlcek, M.; Frossard, M.; Laggner, A.N. Can brain natriuretic peptide predict outcome after cardiac arrest? An observational study. Resuscitation, 2007, 74(3), 439-445.
[http://dx.doi.org/10.1016/j.resuscitation.2007.02.001] [PMID: 17451863]
[12]
Chappell, D.; Jacob, M.; Hofmann-Kiefer, K.; Bruegger, D.; Rehm, M.; Conzen, P.; Welsch, U.; Becker, B.F. Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology, 2007, 107(5), 776-784.
[http://dx.doi.org/10.1097/01.anes.0000286984.39328.96] [PMID: 18073553]
[13]
Cain, D.W.; Cidlowski, J.A. Immune regulation by glucocorticoids. Nat. Rev. Immunol., 2017, 17(4), 233-247.
[http://dx.doi.org/10.1038/nri.2017.1] [PMID: 28192415]
[14]
Hékimian, G.; Baugnon, T.; Thuong, M.; Monchi, M.; Dabbane, H.; Jaby, D.; Rhaoui, A.; Laurent, I.; Moret, G.; Fraisse, F.; Adrie, C. Cortisol levels and adrenal reserve after successful cardiac arrest resuscitation. Shock, 2004, 22(2), 116-119.
[http://dx.doi.org/10.1097/01.shk.0000132489.79498.c7] [PMID: 15257083]
[15]
Kim, J.J.; Lim, Y.S.; Shin, J.H.; Yang, H.J.; Kim, J.K.; Hyun, S.Y.; Rhoo, I.; Hwang, S.Y.; Lee, G. Relative adrenal insufficiency after cardiac arrest: Impact on postresuscitation disease outcome. Am. J. Emerg. Med., 2006, 24(6), 684-688.
[http://dx.doi.org/10.1016/j.ajem.2006.02.017] [PMID: 16984836]
[16]
Kim, J.J.; Hyun, S.Y.; Hwang, S.Y.; Jung, Y.B.; Shin, J.H.; Lim, Y.S.; Cho, J.S.; Yang, H.J.; Lee, G. Hormonal responses upon return of spontaneous circulation after cardiac arrest: A retrospective cohort study. Crit. Care, 2011, 15(1), R53.
[http://dx.doi.org/10.1186/cc10019] [PMID: 21299901]
[17]
Schultz, C.H.; Rivers, E.P.; Feldkamp, C.S.; Goad, E.G.; Smithline, H.A.; Martin, G.B.; Fath, J.J.; Wortsman, J.; Nowak, R.M. A characterization of hypothalamic-pituitary-adrenal axis function during and after human cardiac arrest. Crit. Care Med., 1993, 21(9), 1339-1347.
[http://dx.doi.org/10.1097/00003246-199309000-00018] [PMID: 8396524]
[18]
Wells, G. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. 2004. http://www, ohri ca/programs/clinical_epidemiology oxford htm.
[19]
Higgins, J.P.; Altman, D.G.; Gøtzsche, P.C.; Jüni, P.; Moher, D.; Oxman, A.D.; Savovic, J.; Schulz, K.F.; Weeks, L.; Sterne, J.A. The cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ, 2011, 343, d5928.
[http://dx.doi.org/10.1136/bmj.d5928] [PMID: 22008217]
[20]
Donnino, M.W.; Andersen, L.W.; Berg, K.M.; Chase, M.; Sherwin, R.; Smithline, H.; Carney, E.; Ngo, L.; Patel, P.V.; Liu, X.; Cutlip, D.; Zimetbaum, P.; Cocchi, M.N. Corticosteroid therapy in refractory shock following cardiac arrest: a randomized, double-blind, placebo-controlled, trial. Crit. Care, 2016, 20(1), 82.
[http://dx.doi.org/10.1186/s13054-016-1257-x] [PMID: 27038920]
[21]
Tsai, M-S.; Huang, C-H.; Chang, W-T.; Chen, W.J.; Hsu, C.Y.; Hsieh, C.C.; Yang, C.W.; Chiang, W.C.; Ma, M.H.; Chen, S.C. The effect of hydrocortisone on the outcome of out-of-hospital cardiac arrest patients: A pilot study. Am. J. Emerg. Med., 2007, 25(3), 318-325.
[http://dx.doi.org/10.1016/j.ajem.2006.12.007] [PMID: 17349907]
[22]
Tsai, M-S.; Chuang, P-Y.; Huang, C-H.; Tang, C.H.; Yu, P.H.; Chang, W.T.; Chen, W.J. Postarrest steroid use may improve outcomes of cardiac arrest survivors. Crit. Care Med., 2019, 47(2), 167-175.
[http://dx.doi.org/10.1097/CCM.0000000000003468] [PMID: 30308548]
[23]
Tsai, M-S.; Chuang, P-Y.; Yu, P-H.; Huang, C.H.; Tang, C.H.; Chang, W.T.; Chen, W.J. Glucocorticoid use during cardiopulmonary resuscitation may be beneficial for cardiac arrest. Int. J. Cardiol., 2016, 222, 629-635.
[http://dx.doi.org/10.1016/j.ijcard.2016.08.017] [PMID: 27517652]
[24]
Jastremski, M.; Sutton-Tyrrell, K.; Vaagenes, P.; Abramson, N.; Heiselman, D.; Safar, P. Glucocorticoid treatment does not improve neurological recovery following cardiac arrest. JAMA, 1989, 262(24), 3427-3430.
[http://dx.doi.org/10.1001/jama.1989.03430240063030] [PMID: 2685382]
[25]
Niimura, T.; Zamami, Y.; Koyama, T.; Izawa-Ishizawa, Y.; Miyake, M.; Koga, T.; Harada, K.; Ohshima, A.; Imai, T.; Kondo, Y.; Imanishi, M.; Takechi, K.; Fukushima, K.; Horinouchi, Y.; Ikeda, Y.; Fujino, H.; Tsuchiya, K.; Tamaki, T.; Hinotsu, S.; Kano, M.R.; Ishizawa, K. Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest. Sci. Rep., 2017, 7(1), 17919.
[http://dx.doi.org/10.1038/s41598-017-17686-3] [PMID: 29263333]
[26]
Grafton, S.T.; Longstreth, W.T.Jr. Steroids after cardiac arrest: a retrospective study with concurrent, nonrandomized controls. Neurology, 1988, 38(8), 1315-1316.
[http://dx.doi.org/10.1212/WNL.38.8.1315] [PMID: 3399081]
[27]
Marik, P.E. The role of glucocorticoids as adjunctive treatment for sepsis in the modern era. Lancet Respir. Med., 2018, 6(10), 793-800.
[http://dx.doi.org/10.1016/S2213-2600(18)30265-0] [PMID: 30006071]
[28]
Adrie, C.; Adib-Conquy, M.; Laurent, I.; Monchi, M.; Vinsonneau, C.; Fitting, C.; Fraisse, F.; Dinh-Xuan, A.T.; Carli, P.; Spaulding, C.; Dhainaut, J.F.; Cavaillon, J.M. Successful cardiopulmonary resuscitation after cardiac arrest as a “sepsis-like” syndrome. Circulation, 2002, 106(5), 562-568.
[http://dx.doi.org/10.1161/01.CIR.0000023891.80661.AD] [PMID: 12147537]
[29]
Omar, Y.G.; Massey, M.; Andersen, L.W.; Giberson, T.A.; Berg, K.; Cocchi, M.N.; Shapiro, N.I.; Donnino, M.W. Sublingual microcirculation is impaired in post-cardiac arrest patients. Resuscitation, 2013, 84(12), 1717-1722.
[http://dx.doi.org/10.1016/j.resuscitation.2013.07.012] [PMID: 23871865]
[30]
Keh, D.; Boehnke, T.; Weber-Cartens, S.; Schulz, C.; Ahlers, O.; Bercker, S.; Volk, H.D.; Doecke, W.D.; Falke, K.J.; Gerlach, H. Immunologic and hemodynamic effects of “low-dose” hydrocortisone in septic shock: A double-blind, randomized, placebo-controlled, crossover study. Am. J. Respir. Crit. Care Med., 2003, 167(4), 512-520.
[http://dx.doi.org/10.1164/rccm.200205-446OC] [PMID: 12426230]
[31]
Aguilar, D.; Strom, J.; Chen, Q.M. Glucocorticoid induced leucine zipper inhibits apoptosis of cardiomyocytes by doxorubicin. Toxicol. Appl. Pharmacol., 2014, 276(1), 55-62.
[http://dx.doi.org/10.1016/j.taap.2014.01.013] [PMID: 24480152]
[32]
Oh, H.Y.; Namkoong, S.; Lee, S.J.; Por, E.; Kim, C.K.; Billiar, T.R.; Han, J.A.; Ha, K.S.; Chung, H.T.; Kwon, Y.G.; Lee, H.; Kim, Y.M. Dexamethasone protects primary cultured hepatocytes from death receptor-mediated apoptosis by upregulation of cFLIP. Cell Death Differ., 2006, 13(3), 512-523.
[http://dx.doi.org/10.1038/sj.cdd.4401771] [PMID: 16167066]
[33]
van der Poll, T.; Lowry, S.F. Lipopolysaccharide-induced interleukin 8 production by human whole blood is enhanced by epinephrine and inhibited by hydrocortisone. Infect. Immun., 1997, 65(6), 2378-2381.
[http://dx.doi.org/10.1128/IAI.65.6.2378-2381.1997] [PMID: 9169777]
[34]
Katz, L.; Vaagenes, P.; Safar, P.; Diven, W. Brain enzyme changes as markers of brain damage in rat cardiac arrest model. Effects of corticosteroid therapy. Resuscitation, 1989, 17(1), 39-53.
[http://dx.doi.org/10.1016/0300-9572(89)90078-6] [PMID: 2538900]
[35]
Vaahersalo, J.; Skrifvars, M.B.; Pulkki, K.; Stridsberg, M.; Røsjø, H.; Hovilehto, S.; Tiainen, M.; Varpula, T.; Pettilä, V.; Ruokonen, E. Admission interleukin-6 is associated with post resuscitation organ dysfunction and predicts long-term neurological outcome after out-of-hospital ventricular fibrillation. Resuscitation, 2014, 85(11), 1573- 1579.
[http://dx.doi.org/10.1016/j.resuscitation.2014.08.036] [PMID: 25238742]
[36]
Peberdy, M.A.; Andersen, L.W.; Abbate, A.; Thacker, L.R.; Gaieski, D.; Abella, B.S.; Grossestreuer, A.V.; Rittenberger, J.C.; Clore, J.; Ornato, J.; Cocchi, M.N.; Callaway, C.; Donnino, M. Inflammatory markers following resuscitation from out-of-hospital cardiac arrest-A prospective multicenter observational study. Resuscitation, 2016, 103, 117-124.
[http://dx.doi.org/10.1016/j.resuscitation.2016.01.006] [PMID: 26826561]
[37]
Hafezi-Moghadam, A.; Simoncini, T.; Yang, Z.; Limbourg, F.P.; Plumier, J.C.; Rebsamen, M.C.; Hsieh, C.M.; Chui, D.S.; Thomas, K.L.; Prorock, A.J.; Laubach, V.E.; Moskowitz, M.A.; French, B.A.; Ley, K.; Liao, J.K. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat. Med., 2002, 8(5), 473-479.
[http://dx.doi.org/10.1038/nm0502-473] [PMID: 11984591]
[38]
Mukaida, N.; Zachariae, C.C.; Gusella, G.L.; Matsushima, K. Dexamethasone inhibits the induction of monocyte chemotactic-activating factor production by IL-1 or tumor necrosis factor. J. Immunol., 1991, 146(4), 1212-1215.
[PMID: 1991962]
[39]
Grünfeld, J-P.; Eloy, L. Glucocorticoids modulate vascular reactivity in the rat. Hypertension, 1987, 10(6), 608-618.
[http://dx.doi.org/10.1161/01.HYP.10.6.608] [PMID: 3692572]
[40]
Romero, I.A.; Radewicz, K.; Jubin, E.; Michel, C.C.; Greenwood, J.; Couraud, P.O.; Adamson, P. Changes in cytoskeletal and tight junctional proteins correlate with decreased permeability induced by dexamethasone in cultured rat brain endothelial cells. Neurosci. Lett., 2003, 344(2), 112-116.
[http://dx.doi.org/10.1016/S0304-3940(03)00348-3] [PMID: 12782340]
[41]
Constantinescu, A.A.; Vink, H.; Spaan, J.A. Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface. Arterioscler. Thromb. Vasc. Biol., 2003, 23(9), 1541-1547.
[http://dx.doi.org/10.1161/01.ATV.0000085630.24353.3D] [PMID: 12855481]
[42]
Vink, H.; Constantinescu, A.A.; Spaan, J.A. Oxidized lipoproteins degrade the endothelial surface layer : Implications for platelet-endothelial cell adhesion. Circulation, 2000, 101(13), 1500-1502.
[http://dx.doi.org/10.1161/01.CIR.101.13.1500] [PMID: 10747340]
[43]
Berger, S. Survival from out-of-hospital cardiac arrest: are we beginning to see progress? Am Heart Assoc, 2017, 6(9)e007469.
[http://dx.doi.org/10.1161/JAHA.117.007469] [PMID: 28939721]
[44]
Graham, R.; McCoy, M.A.; Schultz, A.M. Understanding the public health burden of cardiac arrest: The need for national surveillance. Strategies to improve cardiac arrest survival: A time to act; National Academies Press: US, 2015.
[45]
Laver, S.; Farrow, C.; Turner, D.; Nolan, J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med., 2004, 30(11), 2126-2128.
[http://dx.doi.org/10.1007/s00134-004-2425-z] [PMID: 15365608]
[46]
Miller, J.B.; Donnino, M.W.; Rogan, M.; Goyal, N. Relative adrenal insufficiency in post-cardiac arrest shock is under-recognized. Resuscitation, 2008, 76(2), 221-225.
[http://dx.doi.org/10.1016/j.resuscitation.2007.07.034] [PMID: 17875353]
[47]
Pene, F.; Hyvernat, H.; Mallet, V.; Cariou, A.; Carli, P.; Spaulding, C.; Dugue, M.A.; Mira, J.P. Prognostic value of relative adrenal insufficiency after out-of-hospital cardiac arrest. Intensive Care Med., 2005, 31(5), 627-633.
[http://dx.doi.org/10.1007/s00134-005-2603-7] [PMID: 15838680]
[48]
Tavakoli, N.; Bidari, A.; Shams Vahdati, S. Serum cortisol levels as a predictor of neurologic survival insuccessfully resuscitated victims of cardiopulmonary arrest. J. Cardiovasc. Thorac. Res., 2012, 4(4), 107-111.
[PMID: 24250997]
[49]
Chalkias, A.; Xanthos, T. Post-cardiac arrest syndrome: Mechanisms and evaluation of adrenal insufficiency. World J. Crit. Care Med., 2012, 1(1), 4-9.
[http://dx.doi.org/10.5492/wjccm.v1.i1.4] [PMID: 24701395]
[50]
Matsumura, M.; Kakishita, H.; Suzuki, M.; Banba, N.; Hattori, Y. Dexamethasone suppresses iNOS gene expression by inhibiting NF-kappaB in vascular smooth muscle cells. Life Sci., 2001, 69(9), 1067-1077.
[http://dx.doi.org/10.1016/S0024-3205(01)01196-1] [PMID: 11508649]
[51]
Ito, T.; Saitoh, D.; Takasu, A.; Kiyozumi, T.; Sakamoto, T.; Okada, Y. Serum cortisol as a predictive marker of the outcome in patients resuscitated after cardiopulmonary arrest. Resuscitation, 2004, 62(1), 55-60.
[http://dx.doi.org/10.1016/j.resuscitation.2004.02.004] [PMID: 15246584]
[52]
Lindner, K.H.; Strohmenger, H.U.; Ensinger, H.; Hetzel, W.D.; Ahnefeld, F.W.; Georgieff, M. Stress hormone response during and after cardiopulmonary resuscitation. Anesthesiology, 1992, 77(4), 662-668.
[http://dx.doi.org/10.1097/00000542-199210000-00008] [PMID: 1329579]
[53]
Foley, P.J.; Tacker, W.A.; Wortsman, J.; Frank, S.; Cryer, P.E. Plasma catecholamine and serum cortisol responses to experimental cardiac arrest in dogs. Am. J. Physiol., 1987, 253(3 Pt 1), E283-E289.
[PMID: 3631258]
[54]
Kornberger, E.; Prengel, A.W.; Krismer, A.; Schwarz, B.; Wenzel, V.; Lindner, K.H.; Mair, P. Vasopressin-mediated adrenocorticotropin release increases plasma cortisol concentrations during cardiopulmonary resuscitation. Crit. Care Med., 2000, 28(10), 3517-3521.
[http://dx.doi.org/10.1097/00003246-200010000-00028] [PMID: 11057810]
[55]
Smithline, H.; Rivers, E.; Appleton, T.; Nowak, R. Corticosteroid supplementation during cardiac arrest in rats. Resuscitation, 1993, 25(3), 257-264.
[http://dx.doi.org/10.1016/0300-9572(93)90123-8] [PMID: 8351423]
[56]
Mentzelopoulos, S.D.; Zakynthinos, S.G.; Tzoufi, M.; Katsios, N.; Papastylianou, A.; Gkisioti, S.; Stathopoulos, A.; Kollintza, A.; Stamataki, E.; Roussos, C. Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest. Arch. Intern. Med., 2009, 169(1), 15-24.
[http://dx.doi.org/10.1001/archinternmed.2008.509] [PMID: 19139319]
[57]
Mentzelopoulos, S.D.; Malachias, S.; Chamos, C.; Konstantopoulos, D.; Ntaidou, T.; Papastylianou, A.; Kolliantzaki, I.; Theodoridi, M.; Ischaki, H.; Makris, D.; Zakynthinos, E.; Zintzaras, E.; Sourlas, S.; Aloizos, S.; Zakynthinos, S.G. Vasopressin, steroids, and epinephrine and neurologically favorable survival after in-hospital cardiac arrest: A randomized clinical trial. JAMA, 2013, 310(3), 270-279.
[http://dx.doi.org/10.1001/jama.2013.7832] [PMID: 23860985]
[58]
American Heart Association, 2015. Available at: https://eccguidelines.heart.org/index.php/circulation/cpr-ecc-guidelines-2/

Rights & Permissions Print Cite
Article Metrics
64
1
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy